Alps Advisors Inc Royalty Pharma PLC Transaction History
Alps Advisors Inc
- $17.8 Billion
- Q3 2025
A detailed history of Alps Advisors Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Alps Advisors Inc holds 553,124 shares of RPRX stock, worth $22.6 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
553,124Holding current value
$22.6 Million% of portfolio
0.11%Shares
5 transactions
Others Institutions Holding RPRX
# of Institutions
508Shares Held
309MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.9 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY23MShares$939 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$892 Million0.14% of portfolio
-
Baillie Gifford & CO17.4MShares$708 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$498 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...